Empire Genomics: Empire Genomics Corp. Awarded Molecular Analyzers, Reagents Agreement with Premier, Inc.

BUFFALO, N.Y., April 9, 2024 /PRNewswire/ -- Empire Genomics Corp. has been awarded a national group purchasing agreement for Molecular Analyzers, Reagents with Premier, Inc. Effective 02/01/2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for FISH (Fluorescent in situ Hybridization) Probes."Empire Genomics is proud to have been chosen for the Premier GPO molecular contract, which is a testament to our commitment to quality and innovation in cancer diagnostics. We offer an extensive selection of over one million FISH and CISH probes, providing researchers and clinicians the flexibility required for research breakthroughs and critical diagnostic decisions. Our probes can be run manually or, for enhanced efficiency, automated with the Biocare Medical ONCORE Pro system-making Empire the perfect solution for any laboratory's needs."- Luis ...Full story available on Benzinga.com